About BPH
An enlarged prostate or BPH (benign prostatic hyperplasia) is a common affliction of older men.
Nymox has developed a new treatment for BPH, NX-1207. NX-1207 is entering Phase 3 clinical trials, the last stage before applying for FDA approval. If approved, the drug could offer new hope for the millions of men suffering from BPH.
More information about NX-1207 is available here.
More information about BPH for patients is available here.
